Frieder Keller

1.6k total citations · 1 hit paper
29 papers, 1.1k citations indexed

About

Frieder Keller is a scholar working on Pharmacology, Nephrology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Frieder Keller has authored 29 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pharmacology, 5 papers in Nephrology and 5 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Frieder Keller's work include Antibiotics Pharmacokinetics and Efficacy (7 papers), Pharmacogenetics and Drug Metabolism (5 papers) and Drug Transport and Resistance Mechanisms (4 papers). Frieder Keller is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (7 papers), Pharmacogenetics and Drug Metabolism (5 papers) and Drug Transport and Resistance Mechanisms (4 papers). Frieder Keller collaborates with scholars based in Germany, United States and Netherlands. Frieder Keller's co-authors include David Czock, Franz Maximilian Rasche, Joachim Böhler, Johannes Donauer, Dieter Schaarschmidt, Gerald Steinbach, Hanna M. Seidling, A. Mertz, Mette Heringa and Michael Giehl and has published in prestigious journals such as Kidney International, American Journal of Kidney Diseases and Clinical Pharmacology & Therapeutics.

In The Last Decade

Frieder Keller

28 papers receiving 1.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Pharmacokinetics and Pharmacodynamics of Systemically Administered Glucocorticoids

2005 662 citations David Czock, Frieder Keller et al. Clinical Pharmacokinetics profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Frieder Keller Germany	13	203	159	150	143	135	29	1.1k
Franz Maximilian Rasche Germany	13	206 1.0×	189 1.2×	172 1.1×	66 0.5×	166 1.2×	36	1.2k
M. Godin France	22	149 0.7×	102 0.6×	295 2.0×	188 1.3×	222 1.6×	94	1.4k
Noël Zahr France	23	288 1.4×	78 0.5×	92 0.6×	213 1.5×	124 0.9×	64	1.8k
Bonnie Hepburn United States	11	219 1.1×	87 0.5×	71 0.5×	134 0.9×	258 1.9×	19	1.7k
David Colantonio Canada	18	186 0.9×	204 1.3×	167 1.1×	45 0.3×	169 1.3×	39	1.5k
Shaul M. Shasha Israel	22	169 0.8×	86 0.5×	242 1.6×	35 0.2×	139 1.0×	61	1.3k
Stefano Federico Italy	22	280 1.4×	62 0.4×	237 1.6×	46 0.3×	212 1.6×	66	1.4k
Amit Gupta India	13	132 0.7×	176 1.1×	133 0.9×	36 0.3×	162 1.2×	56	1.0k
David De Bels Belgium	18	202 1.0×	57 0.4×	63 0.4×	86 0.6×	157 1.2×	81	1.0k
Rosalia Aloe Italy	24	207 1.0×	136 0.9×	112 0.7×	40 0.3×	216 1.6×	88	1.5k

Countries citing papers authored by Frieder Keller

Since Specialization

Citations

This map shows the geographic impact of Frieder Keller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frieder Keller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frieder Keller more than expected).

Fields of papers citing papers by Frieder Keller

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frieder Keller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frieder Keller. The network helps show where Frieder Keller may publish in the future.

Co-authorship network of co-authors of Frieder Keller

This figure shows the co-authorship network connecting the top 25 collaborators of Frieder Keller. A scholar is included among the top collaborators of Frieder Keller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frieder Keller. Frieder Keller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Keller, Frieder, et al.. (2023). Enemy or friend: the personal and the factual patient-physician relationship. Frontiers in Medicine. 10. 1098305–1098305.

Rasche, Franz Maximilian, et al.. (2016). Why, when and how should immunosuppressive therapy considered in patients with immunoglobulin A nephropathy?. Clinical & Experimental Immunology. 186(2). 115–133. 11 indexed citations

Czock, David, et al.. (2015). Suboptimal antimicrobial drug exposure in patients with renal impairment. International Journal of Clinical Pharmacy. 37(5). 906–916. 3 indexed citations

Czock, David, Frieder Keller, & Hanna M. Seidling. (2012). Pharmacokinetic predictions for patients with renal impairment: focus on peptides and protein drugs. British Journal of Clinical Pharmacology. 74(1). 66–74. 14 indexed citations

Stracke, Sylvia, Maria Shipkova, Jens Mayer, et al.. (2011). Pharmacokinetics and pharmacodynamics of mycophenolate sodium (EC‐MPS) co‐administered with cyclosporine in the early‐phase post‐kidney transplantation. Clinical Transplantation. 26(1). 57–66. 13 indexed citations

Rothermund, Lars, Myriam Ricarda Lorenz, Angela Schulz, et al.. (2010). Impact of Nephron Number Dosing on Cardiorenal Damage and Effects of ACE Inhibition. American Journal of Hypertension. 24(4). 474–481. 8 indexed citations

Czock, David, Franz Maximilian Rasche, Alexander Carius, et al.. (2007). Pharmacokinetics and Pharmacodynamics of Mycophenolic Acid After Enteric‐Coated Mycophenolate Versus Mycophenolate Mofetil in Patients With Progressive IgA Nephritis. The Journal of Clinical Pharmacology. 47(7). 850–859. 22 indexed citations

Czock, David, Frieder Keller, Mette Heringa, & Franz Maximilian Rasche. (2005). Raloxifene pharmacokinetics in males with normal and impaired renal function. British Journal of Clinical Pharmacology. 59(4). 479–482. 21 indexed citations

Kielstein, Jan T., Michael Stadler, David Czock, et al.. (2005). Dialysate concentration and pharmacokinetics of 2F‐Ara‐A in a patient with acute renal failure. European Journal Of Haematology. 74(6). 533–534. 7 indexed citations

10.

Czock, David, et al.. (2005). Pharmacokinetics and Pharmacodynamics of Systemically Administered Glucocorticoids. Clinical Pharmacokinetics. 44(1). 61–98. 662 indexed citations breakdown →

11.

Heering, Peter, Norbert Braun, Katrin Ivens, et al.. (2004). Cyclosporine A and chlorambucil in the treatment of idiopathic focal segmental glomerulosclerosis. American Journal of Kidney Diseases. 43(1). 10–18. 40 indexed citations

12.

Czock, David, et al.. (2002). Pharmacokinetics and pharmacodynamics of methylprednisolone after one bolus dose compared with two dose fractions. Journal of Clinical Pharmacy and Therapeutics. 27(4). 281–287. 14 indexed citations

13.

Czock, David, Michael Giehl, & Frieder Keller. (2000). A Concept for Pharmacokinetic- Pharmacodynamic Dosage Adjustment in Renal Impairment. Clinical Pharmacokinetics. 38(4). 367–375. 8 indexed citations

14.

Keller, Frieder & David Czock. (1999). Pharmacodynamic half-life and effect-time course in renal impairment. Nephrology Dialysis Transplantation. 14(suppl 4). 6–8. 3 indexed citations

15.

Keller, Frieder, et al.. (1999). Individualized drug dosage in patients treated with continuous hemofiltration. Kidney International. 56(72). S29–S31. 14 indexed citations

16.

Böhler, Joachim, Johannes Donauer, & Frieder Keller. (1999). Pharmacokinetic principles during continuous renal replacement therapy: Drugs and dosage. Kidney International. 56(72). S24–S28. 81 indexed citations

17.

Keller, Frieder, et al.. (1998). Specificity of Cardiac Troponins I and T in Renal Disease. Clinical Chemistry and Laboratory Medicine (CCLM). 36(2). 87–92. 45 indexed citations

18.

Walz, Gerd, Ulrich Kunzendorf, Frieder Keller, et al.. (1990). Soluble Interleukin 2 Receptor and Tissue Polypeptide Antigen Serum Concentrations in End-Stage Renal Failure. The Nephron journals/Nephron journals. 56(2). 157–161. 13 indexed citations

19.

Kunzendorf, Ulrich, et al.. (1990). Control of Renovascular Hypertension by Renal Embolization. American Journal of Nephrology. 10(4). 339–343. 4 indexed citations

20.

Kunzendorf, Ulrich, et al.. (1989). Progression of Renal Failure in Analgesic-Associated Nephropathy. The Nephron journals/Nephron journals. 53(3). 244–249. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact